Innovative Company Focused on Women's Health Completes Record-Breaking Quarter

Disclosures from Ladenburg Thalmann, Viveve Medical Inc., May 12, 2017

ANALYST CERTIFICATION: I, Jeffrey S. Cohen, attest that the views expressed in this research report accurately reflect my personal views about the subject security and issuer. Furthermore, no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views expressed in this research report, provided, however, that:

The research analyst primarily responsible for the preparation of this research report has or will receive compensation based upon various factors, including the volume of trading at the firm in the subject security, as well as the firm’s total revenues, a portion of which is generated by investment banking activities.

COMPANY SPECIFIC DISCLOSURES:

Ladenburg Thalmann & Co. Inc. makes a market in Viveve Medical, Inc.

Ladenburg Thalmann & Co. Inc. has managed or co-managed a public offering for Viveve Medical, Inc. within the past 12 months.

Ladenburg Thalmann & Co. Inc. expects to receive compensation for investment banking and/or advisory services from Viveve Medical, Inc. within the next 3 months.

Ladenburg Thalmann & Co. Inc received compensation for investment banking services from Viveve Medical, Inc. within the past 12 months.

Ladenburg Thalmann & Co. Inc had an investment banking relationship with Viveve Medical, Inc. within the last 12 months.

Disclosures from Maxim Group, Viveve Medical, May 12, 2017

I, Anthony Vendetti, attest that the views expressed in this research report accurately reflect my personal views about the subject security and issuer. Furthermore, no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views expressed in this research report.

The research analyst(s) primarily responsible for the preparation of this research report have received compensation based upon various factors, including the firm’s total revenues, a portion of which is generated by investment banking activities.

Maxim Group makes a market in Viveve Medical, Inc.

Maxim Group managed/co-managed/acted as placement agent for an offering of the securities for Viveve Medical, Inc. in the past 12 months.

Maxim Group received compensation for investment banking services from Viveve Medical, Inc. in the past 12 months.

Maxim Group expects to receive or intends to seek compensation for investment banking services from Viveve Medical, Inc. in the next 3 months.

B. Riley & Company, Viveve Medical Inc., May 12, 2017

I, Greg Chodaczek, certify that this report reflects my personal beliefs about this company and that no portion of my compensation was, is or will be directly or indirectly related to the specific recommendations or views discussed in this report.

B. Riley & Co. LLC does and seeks to do business with companies covered in research reports.

A portion of this analyst's compensation is based on the sales, trading and investment banking activities of B. Riley & Co. LLC.

B. Riley & Co. LLC makes a market in the securities of the company covered in this report.